St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Also called LLy, LBL, acute lymphoblastic lymphoma, T-lymphoblastic lymphoma (T-LL), B-lymphoblastic lymphoma (B-LL), precursor lymphoblastic lymphoma
Lymphoblastic lymphoma (LLy or LBL) is a type of cancer called non-Hodgkin lymphoma, which affects white blood cells called lymphocytes. These cells are important for fighting infections and are made from cells in the bone marrow called lymphoblasts.
Changes in these cells may affect their function, and they can become cancerous. These cancerous cells can spread to other parts of the body, such as the lymph nodes and the thymus gland, which lies in the upper part of the chest.
There are 2 types of lymphoblastic lymphoma:
Learn more about lymphoblastic lymphoma on the Together by St. Jude™ online resource.
The treatment plan for lymphoblastic lymphoma depends on:
Treatment may include:
Your child’s oncologist will discuss treatment options with you.
St. Jude offers clinical trials and cancer research studies for children, teens, and young adults for lymphoblastic lymphoma.
Study goal:
To find out whether a child’s leukemia or lymphoma is low-risk, standard-risk, or high-risk. The risk category will determine the treatment the child will receive.
Age:
1-18 years
Study goal:
To compare the effects of adding inotuzumab and blinatumomab to standard chemotherapy during treatment for newly diagnosed ALL and LLy; to learn whether the length of time that inotuzumab stays in the body affects treatment success or side effects; to learn more about the biological and genetic or genomic traits that predict treatment success and toxicity in children.
Age:
1-18 years
Study goal:
To compare the effects of adding venetoclax, dasatinib, or bortezomib to standard chemotherapy for T-ALL, T-LLy, and MPAL, and to learn more about the biological and genetic or genomic traits that predict treatment success and toxicity in children.
Age:
1-18 years
St. Jude provides the highest quality of care for patients with lymphoblastic lymphoma.
Patients accepted to St. Jude must have a disease we treat and must be referred by a physician or other qualified medical professional. We accept most patients based on their ability to enroll in an open clinical trial.
Call: 1-888-226-4343 (toll-free) or 901-595-4055 (local) | Fax: 901-595-4011 | Email: referralinfo@stjude.org | 24-hour pager: 1-800-349-4334